Holen Sie sich die Stockscreener-App
4.374
6.34%
-0.296
Schlusskurs vom Vortag:
$4.67
Offen:
$4.55
24-Stunden-Volumen:
12,571
Relative Volume:
0.67
Marktkapitalisierung:
$379.13M
Einnahmen:
$163.13M
Nettoeinkommen (Verlust:
$-34.75M
KGV:
32.54
EPS:
0.1344
Netto-Cashflow:
$-231.66M
1W Leistung:
-11.63%
1M Leistung:
-25.22%
6M Leistung:
-46.66%
1J Leistung:
-64.12%
1-Tages-Spanne:
$4.2701
$4.56
1-Wochen-Bereich:
$4.2701
$4.77
52-Wochen-Spanne:
$4.2701
$12.57
Valneva Se Adr Stock (VALN) Company Profile
Vergleichen Sie VALN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| VALN | 4.36 | 379.13M | 163.13M | -34.75M | -231.66M | 0.1344 |
| VRTX | 449.35 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 749.23 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 588.75 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 247.29 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 107.11 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Valneva Se Adr Stock (VALN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-08-03 | Eingeleitet | H.C. Wainwright | Buy |
Valneva Se Adr Aktie (VALN) Neueste Nachrichten
Valneva fera des présentations et rencontrera les investisseurs lors de conférences aux États-Unis et en Europe - GlobeNewswire Inc.
Valneva SE earnings missed by $0.02, revenue fell short of estimates - Investing.com
H.C. Wainwright maintains Buy rating on Valneva SE stock, lowers price target By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Buy rating on Valneva SE stock, lowers price target - Investing.com
Valneva SE Declaration of shares and voting rights - GlobeNewswire Inc.
H.C. Wainwright updates Valneva SE outlook following capital raise, reiterates Buy - Investing.com
H.C. Wainwright updates Valneva SE outlook following capital raise, reiterates Buy By Investing.com - Investing.com South Africa
In-Depth Examination Of 6 Analyst Recommendations For Valneva - Benzinga
Valneva shares hold strong with buy rating on Lyme vaccine data - Investing.com
Wall Street Analysts Predict a 150.41% Upside in Valneva (VALN): Here's What You Should Know - MSN
Favorable VLA15 Phase 2 Study Results Might Boost VALN Stock - Zacks Investment Research
How Much Upside is Left in Valneva (VALN)? Wall Street Analysts Think 135.3% - Yahoo Finance
Can Valneva (VALN) Climb 149.04% to Reach the Level Wall Street Analysts Expect? - Zacks Investment Research
What Analysts Are Saying About Valneva Stock - Benzinga
Valneva (VALN) Gets EC's Approval on Chikungunya Vaccine - Zacks Investment Research
Wall Street Analysts See a 65% Upside in Valneva SE Sponsored ADR (VALN): Can the Stock Really Move This High? - Yahoo New Zealand News
Valneva's (VALN) CHIKV Vaccine Gets Health Canada's Approval - Yahoo Finance
Valneva (VALN) Stock Down 53% in the Past Year: Here's Why - Yahoo Sport Australia
Valneva SE Sponsored ADR (VALN) Stock Jumps 93.1%: Will It Continue to Soar? - Yahoo New Zealand News
Valneva (VALN) Stock Down 61.5% in the Past Year: Here's Why - Yahoo Lifestyle UK
Earnings call: Valneva reports robust growth and strategic R&D focus By Investing.com - Investing.com South Africa
France stocks mixed at close of trade; CAC 40 up 0.34% By Investing.com - Investing.com
France stocks mixed at close of trade; CAC 40 up 0.91% - Investing.com
What Makes Valneva SE Sponsored ADR (VALN) a New Buy Stock - Yahoo Finance
Valneva (VALN) Up on Antibody Persistence Data on Chikungunya Jab - Yahoo Lifestyle Singapore
Valneva (VALN) Down on its COVID-19 Vaccine Update in Europe - Zacks Investment Research
5 Top Health Care Stocks To Watch In The Stock Market Today - Stock Market
Valneva Stock Is Jumping on European Vaccine Supply Deal - Barron's
Valneva Stock Surges After EU Vaccine Deal - Investing.com
Valneva Shares Off 12% On Share Offering News By Investing.com - Investing.com UK
EU set to sign off new Pfizer vaccine contract as soon as Friday - Luxembourg Times
Valneva Races Ahead in Stock Market Even as Vaccine Lags Behind - Bloomberg
Shareholder Structure - Valneva
Stock Price - Valneva
Finanzdaten der Valneva Se Adr-Aktie (VALN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):